Mechanical Structure Complications After Acute Myocardial Infarction (MSC-AMI)

November 25, 2019 updated by: Yan Wang, Xiamen Cardiovascular Hospital, Xiamen University

Comparative Risk Factors of Mechanical Structure Complications After Acute Myocardial Infarction

To determine the incidence and factors associated with heart rupture (HR) in acute myocardial infarction patients.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

We compared characteristics and angiographic patterns of heart rupture and without heart rupture patients enrolled in the trial.

Study Type

Observational

Enrollment (Anticipated)

35621

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Fujian
      • Xiamen, Fujian, China, 361000
        • Recruiting
        • Xiamen Cardiovascular Hospital Xiamen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population of acute myocardial infarction (STEMI or NSTEMI) patients.

Description

Inclusion Criteria:

1. Patients be admitted for acute myocardial infarction (STEMI or NSTEMI)

Exclusion Criteria:

1. Non-cardiovascular comorbidity for AMI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Mechanical Complications
Include free wall ventricular rupture and ventricular septal rupture
Free wall rupture and Ventricular septal rupture
Non-Mechanical Complications
Mechanical complications were not included in patients with AMI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rupture
Time Frame: Mortality 30 days
Includee free wall ventricular rupture and ventricular septal rupture
Mortality 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yan Wang, PhD, Xiamen Cardiovascular Hospital, Xiamen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2011

Primary Completion (Anticipated)

December 31, 2019

Study Completion (Anticipated)

January 31, 2020

Study Registration Dates

First Submitted

September 24, 2019

First Submitted That Met QC Criteria

September 24, 2019

First Posted (Actual)

September 26, 2019

Study Record Updates

Last Update Posted (Actual)

November 26, 2019

Last Update Submitted That Met QC Criteria

November 25, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Myocardial Infarction

Clinical Trials on Heart rupture

3
Subscribe